Shock in Pediatrics Treatment & Management

  • Author: Adam J Schwarz, MD; Chief Editor: Timothy E Corden, MD   more...
 
Updated: Mar 15, 2012
 

Approach Considerations

Regardless of the cause of shock, the ABCs (airway, breathing, circulation) must be immediately evaluated and stabilized. Do not delay this initial stabilization for further workup and imaging studies. The patient's airway must be patent, and the patient must be adequately oxygenated and ventilated. Initially, administer 100% supplemental oxygen at a high flow rate. If the patient is in respiratory distress, consider intubating and providing mechanical ventilation.

Stabilizing the airway and providing mechanical ventilation may relieve the patient's metabolic work of breathing and may facilitate elimination of carbon dioxide, helping to compensate the coexistent metabolic acidosis. Place the patient on appropriate noninvasive monitors, such as a pulse oximeter and cardiorespiratory monitor, and obtain a simple bedside glucose measurement.

Once the airway has been stabilized, if necessary, and adequate ventilation and administration of oxygen have been ensured, immediately place attention on improving circulation and systemic oxygen delivery (DO2). Circulatory improvement is achieved via volume expansion and, if necessary, pharmacologic therapy with vasopressors and cardiac inotropic agents.

If sepsis is a concern, initial coverage with empiric antibiotics is essential to eliminating the precipitating cause of shock. The choice of agents may vary, depending on the patient’s age and previous antibiotic exposure.

Neonates are often started on a combination of ampicillin and gentamicin. Older infants and children may be covered with a third-generation cephalosporin, possibly along with expanded gram-positive organism coverage with vancomycin initially. Management of significant septic shock should be multidisciplinary and should involve the resources of infectious disease specialists when available.[17]

Next

Volume Expansion

The major physiologic abnormality in most forms of pediatric shock is either an absolute or a relative intravascular hypovolemia. Dehydration, hemorrhage, sepsis, and other distributive etiologies all cause intravascular hypovolemia with a reduction in cardiac ventricular filling volume (preload).

Children with hypovolemic shock who receive appropriate aggressive fluid resuscitation within the first hour of resuscitation have the most optimal chance of survival and recovery. Unlike adults, children do not have as pronounced a susceptibility to fluid-related complications, such as pulmonary edema. Therefore, the therapy of choice is rapid and aggressive fluid resuscitation.

Procedure

If possible, place a minimum of 2 large-bore, free-flowing intravenous (IV) catheters. If vascular access is not easily and readily achieved, then an intraosseous (IO) needle may be placed into the bone marrow for rapid fluid administration. Such an IO line can be considered as good as an IV line for the purpose of any fluid or medication administration necessary for the acute resuscitation of a compromised infant or child in shock.[18]

Administer 20mL/kg of an isotonic crystalloid infusion, such as 0.9% isotonic sodium chloride or lactated Ringer solution, over 5 minutes or less. If the volume infusion is administered through an IO line, the resistance may be higher than in an IV line, and the volume may need to be pushed manually with a syringe. So long as the volume is infusing without evidence of local swelling at the IO insertion site or in the tissue posterior to the IO, the fluid is passing into the marrow cavity and hence into the intravascular space.

As soon as the initial volume of fluid (20mL/kg) has been infused, reevaluate the patient. If the patient retains the clinical appearance of shock, immediately infuse another 20mL/kg and repeat the cycle. If more than 2-3 volumes of crystalloid have been infused into a patient at risk for hemorrhage (eg, from trauma), administer blood or packed RBCs (PRBCs). A child with severe hypovolemia or sepsis may require more than 60mL/kg of volume in the first hour of resuscitation, often within the first 15 minutes.

In one study of survival in children with septic shock, children who received on average of 65mL/kg of volume in the first hour had a statistically increased chance of survival compared with those who received less than 40mL/kg in the first hour.[19] Simply put, children who receive appropriate, yet aggressive, fluid resuscitation early have the best chance of surviving severe septic shock or shock and dehydration.

Of note, a large study in African children presenting with apparent sepsis to resource-limited facilities demonstrated a worse outcome for children treated with what would be considered standard fluid resuscitation by Western practice. These results should be considered when treating children in the region of the world studied. The authors suggest that further study is warranted regarding volume expansion and fluid effects on septic children in different settings and with various etiologies.[20]

An exception to repetitive volume resuscitation in a child with shock is the child who presents with cardiogenic shock. Even so, such a child may still be mildly to moderately dehydrated and could benefit from an initial 20mL/kg of isotonic crystalloid volume expansion. During the initial infusion of fluid for volume expansion, the child can be evaluated for the possibility of cardiogenic shock. If myocardial failure is the root cause of such a patient's poor cardiac output, cardiotropic medications are indicated.

Previous
Next

Dextrose

Dextrose administration is often necessary. Neonates and infants have limited glycogen stores, which may become rapidly depleted during shock, resulting in hypoglycemia. Alternatively, high levels of endogenous and exogenous catecholamines may result in a relative insulin-resistant state that can cause serum hyperglycemia.

Because glucose is the major metabolic substrate, perform a rapid bedside glucose test on all patients who present in shock. If the glucose level is low, provide replacement therapy with IV dextrose. The dose of dextrose is 0.5-1g/kg IV. Dextrose is best provided as a continuous IV infusion.

Previous
Next

Electrolyte and Calcium Stabilization

Calcium mediates excitation-contraction coupling in muscle cells, including cardiac muscle. Shock may cause alterations in available serum ionized calcium levels, despite normal total serum calcium. Furthermore, administered blood products (which contain citrate) may bind free available calcium, additionally decreasing available ionized calcium levels.

The availability of functioning ionized calcium also depends on serum acid-base status; an acid environment favors the dissociation of calcium from proteins, making it available as a cofactor in cell function. Care must be taken not to cause a drop in ionized calcium when treating acidosis.

Therefore, calcium therapy can be useful when treating shock in a patient with documented hypocalcemia. It is also indicated for treating shock caused by arrhythmias precipitated by hyperkalemia, hypermagnesemia, or calcium channel blocker toxicity.

Calcium may be provided either as calcium gluconate or calcium chloride. Calcium chloride has been shown to produce higher and more consistent levels of available calcium and, therefore, is recommended in the acute resuscitation of a child in shock.[21] The recommended dose is 10-20mg/kg (0.1-0.2mL/kg of calcium chloride 10%) IV administered at an infusion rate that does not exceed 100mg/min IV. Further therapy may be guided by repeat plasma ionized calcium measurements.

Previous
Next

Bicarbonate

Sodium bicarbonate use in the treatment of shock is controversial. During shock, acidosis develops, which impairs myocardial contractility and optimal function of catecholamines. However, treatment with bicarbonate may worsen intracellular acidosis while it corrects serum acidosis.

This occurs because bicarbonate is an ion that does not readily traverse semipermeable cell membranes. Hence, bicarbonate combines with acid in serum, resulting in the production of carbon dioxide and water, as defined by the Henderson-Hasselbalch equation.

If the increased carbon dioxide is not removed via ventilation, it readily enters the cell and drives the Henderson-Hasselbalch reaction in the opposite direction, increasing intracellular acidosis. Worsened myocardial intracellular acidosis may result in a decrease in myocardial contractility.[22, 23] In addition, bicarbonate administration may result in hypernatremia and hyperosmolality, decreasing the availability of ionized calcium.

Finally, laboratory and clinical data have not demonstrated that bicarbonate administration improves the ability to defibrillate, improves DO2, or improves survival rates in shock and cardiac arrest.[24, 25, 26] Studies in patients with cardiovascular arrest have not demonstrated improved survival rates associated with the use of bicarbonate. Thus, acidosis that results from shock should ideally be corrected with increased perfusion from volume supplementation and judicious use of cardiotropic medications together with optimal ventilation.

Bicarbonate replacement therapy

In patients with persistent shock or ongoing bicarbonate loss (eg, severe diarrhea), careful replacement of bicarbonate may be indicated. The appropriate dose of bicarbonate may be calculated from the known base deficit obtained from an arterial blood gas (ABG) sample according to the following formula:

HCO3- (mEq) = Base deficit × patient's weight (in kg) × 0.3

Generally, a dose equivalent to half of the calculated bicarbonate deficit may be administered initially, and repeat acid-base status may be determined. Alternatively, 0.5-1mEq/kg may be administered if indicated.

Previous
Next

Corticosteroids

The use of corticosteroids in shock, particularly septic shock, is controversial. Many large-scale, controlled trials in animals and humans have not demonstrated improved outcome with corticosteroid use, and there is some potential associated morbidity.[27] Nevertheless, a question remains as to whether patients in severe septic shock or purpura fulminans have adequate levels of circulating glucocorticoids to support their physiology when severely stressed.

Adrenocortical failure or infarction, known as Waterhouse-Friderichsen syndrome, may result in cardiovascular failure and hyporesponsiveness to catecholamines. In such patients, initiation of stress-dose hydrocortisone, in the range of 50-100mg/m2/day IV, may be beneficial and lifesaving. A serum cortisol level may be drawn prior to initiating the first dose of corticosteroids, and if this random serum cortisol level is low, then replacement doses may be beneficial.

Moreover, some data suggest a potential role for corticosteroid replacement therapy in select patients with septic shock. A study of adult patients with septic shock who had survived 48 hours and were dependent on inotropic agents showed some benefit to treatment with supraphysiologic doses of hydrocortisone.[28]

Patients in the treatment group received 100mg of hydrocortisone IV 3 times a day for 5 days. At the end of 7 days, 68% of the hydrocortisone group had reversal of shock, compared with 21% of controls who received placebo, a difference of 47%. In addition, the mortality rate was 32% in the hydrocortisone group, compared with 63% in controls, although this result did not reach statistical significance.

Use in adrenal insufficiency

Furthermore, select patients may have adrenal insufficiency, rendering them hyporesponsive to administration of catecholamines during resuscitation from shock. Some practitioners evaluate a baseline serum cortisol level in children with fluid-refractory, catecholamine-resistant shock and/or perform a corticotropin stimulation test with 250mcg of corticotropin, treating the patient with hydrocortisone, though the use of such serum measurements has not been shown to result in improved outcomes.

Therapy is continued for patients who prove to have an absolute baseline cortisol level of less than 20mcg/dL and/or a depressed response to the corticotropin stimulation test, with a rise of less than 9mcg/dL at 30 and 60 minutes after administration of corticotropin.[29]

Dosage recommendations generally range from 1-2mg/kg of hydrocortisone IV every 6 hours, though as much as a 50mg/kg bolus followed by the same amount infused over 24 hours has been administered.[30]

Previous
Next

Other Therapies

Obviously, for all causes of shock, the underlying etiology should be identified and treated. If the cause is sepsis, isolate and treat the infectious organism with appropriate antibiotics. If the cause is trauma, then ongoing bleeding may need to be surgically addressed. Convert malignant arrhythmias to normal sinus rhythm as soon as possible.

Other modalities of supportive care must be ensured, such as optimizing and providing adequate nutritional support in patients recovering from shock. Multiple system organ support may be required, including such modalities as mechanical ventilation, renal dialysis, or even extracorporeal membrane oxygenation (ECMO).[31, 32]

All of the therapies discussed here are aimed at restoring adequate perfusion to the tissues and organs of the body as soon as possible. Ongoing support offers the body the opportunity to repair the hypoxic and ischemic damage sustained, with the ultimate goal of functioning, intact patient survival.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Adam J Schwarz, MD  Consulting Staff, Critical Care Division, Pediatric Subspecialty Faculty, Children's Hospital of Orange County

Adam J Schwarz, MD is a member of the following medical societies: American Academy of Pediatrics and Phi Beta Kappa

Disclosure: Nothing to disclose.

Chief Editor

Timothy E Corden, MD  Associate Professor of Pediatrics, Co-Director, Policy Core, Injury Research Center, Medical College of Wisconsin; Associate Director, PICU, Children's Hospital of Wisconsin

Timothy E Corden, MD is a member of the following medical societies: American Academy of Pediatrics, Phi Beta Kappa, Society of Critical Care Medicine, and Wisconsin Medical Society

Disclosure: Nothing to disclose.

Additional Contributors

Barry J Evans, MD Assistant Professor of Pediatrics, Temple University Medical School; Director of Pediatric Critical Care and Pulmonology, Associate Chair for Pediatric Education, Temple University Children's Medical Center

Barry J Evans, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American Thoracic Society, and Society of Critical Care Medicine

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

References
  1. Fisher JD, Nelson DG, Beyersdorf H, Satkowiak LJ. Clinical spectrum of shock in the pediatric emergency department. Pediatr Emerg Care. Sep 2010;26(9):622-5. [Medline].

  2. Tobin JR, Wetzel RC. Shock and multi-organ system failure. In: Rogers MC, ed. Textbook of Pediatric Intensive Care. Baltimore, Md: Lippincott, William & Wilkins; 1996:555-605.

  3. .

  4. Ackerman AD, Singhi S. Pediatric infectious diseases: 2009 update for the Rogers' Textbook of Pediatric Intensive Care. Pediatr Crit Care Med. Jan 2010;11(1):117-23. [Medline].

  5. American Heart Association. Recognition of respiratory failure and shock. In: Chameides L, Hazinski MF, eds. Pediatric Advanced Life Support. Dallas, Tx: American Heart Association; 1997.

  6. Saavedra JM, Harris GD, Li S, Finberg L. Capillary refilling (skin turgor) in the assessment of dehydration. Am J Dis Child. Mar 1991;145(3):296-8. [Medline].

  7. Post F, Weilemann LS, Messow CM, Sinning C, Münzel T. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Crit Care Med. Nov 2008;36(11):3030-7. [Medline].

  8. Domico M, Liao P, Anas N, Mink RB. Elevation of brain natriuretic peptide levels in children with septic shock. Pediatr Crit Care Med. Sep 2008;9(5):478-83. [Medline].

  9. Katz RW, Pollack MM, Weibley RE. Pulmonary artery catheterization in pediatric intensive care. Adv Pediatr. 1983;30:169-90. [Medline].

  10. Pollack MM, Fields AI, Ruttimann UE. Distributions of cardiopulmonary variables in pediatric survivors and nonsurvivors of septic shock. Crit Care Med. Jun 1985;13(6):454-9. [Medline].

  11. Sibbald WJ, Calvin J, Driedger AA. Right and left ventricular preload and diastolic ventricular compliance: implications for therapy in critically ill patients. In: Shoemaker WC, Thompson WL, eds. Critical Care-State of the Art. Fullerton, Calif: Society of Critical Care Medicine; 1982.

  12. [Guideline] Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. Feb 2009;37(2):666-88. [Medline].

  13. de Oliveira CF, de Oliveira DS, Gottschald AF, et al. ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med. Jun 2008;34(6):1065-75. [Medline].

  14. Ferrari M, Mottola L, Quaresima V. Principles, techniques, and limitations of near infrared spectroscopy. Can J Appl Physiol. Aug 2004;29(4):463-87. [Medline].

  15. Adcock LM, Wafelman LS, Hegemier S, et al. Neonatal intensive care applications of near-infrared spectroscopy. Clin Perinatol. Dec 1999;26(4):893-903, ix. [Medline].

  16. Ghanayem NS, Wernovsky G, Hoffman GM. Near-infrared spectroscopy as a hemodynamic monitor in critical illness. Pediatr Crit Care Med. Jul 2011;12(4 Suppl):S27-32. [Medline].

  17. [Guideline] Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. Jan 2008;34(1):17-60. [Medline].

  18. Voigt J, Waltzman M, Lottenberg L. Intraosseous vascular access for in-hospital emergency use: a systematic clinical review of the literature and analysis. Pediatr Emerg Care. Feb 2012;28(2):185-99. [Medline].

  19. Carcillo JA, Davis AL, Zaritsky A. Role of early fluid resuscitation in pediatric septic shock. JAMA. Sep 4 1991;266(9):1242-5. [Medline].

  20. Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med. Jun 30 2011;364(26):2483-95. [Medline].

  21. Broner CW, Stidham GL, Westenkirchner DF, Watson DC. A prospective, randomized, double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children. J Pediatr. Dec 1990;117(6):986-9. [Medline].

  22. Cingolani HE, Mattiazzi AR, Blesa ES, Gonzalez NC. Contractility in isolated mammalian heart muscle after acid-base changes. Circ Res. Mar 1970;26(3):269-78. [Medline].

  23. Pannier JL, Leusen I. Contraction characteristics of papillary muscle during changes in acid-base composition of the bathing-fluid. Arch Int Physiol Biochim. Sep 1968;76(4):624-34. [Medline].

  24. Arieff AI. Indications for use of bicarbonate in patients with metabolic acidosis. Br J Anaesth. Aug 1991;67(2):165-77. [Medline].

  25. Walley KR, Cooper J, Baile EM. Bicarbonate does not improve left ventricular contractility during resuscitation from hypovolemic shock in pigs. J Crit Care. 1992;7:14-21.

  26. Mäkisalo HJ, Soini HO, Nordin AJ, Höckerstedt KA. Effects of bicarbonate therapy on tissue oxygenation during resuscitation of hemorrhagic shock. Crit Care Med. Nov 1989;17(11):1170-4. [Medline].

  27. Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med. Aug 1995;23(8):1430-9. [Medline].

  28. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. Apr 1998;26(4):645-50. [Medline].

  29. [Best Evidence] Pizarro CF, Troster EJ, Damiani D, Carcillo JA. Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med. Apr 2005;33(4):855-9. [Medline].

  30. Carcillo JA, Fields AI. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med. Jun 2002;30(6):1365-78. [Medline].

  31. McCune S, Short BL, Miller MK, Lotze A, Anderson KD. Extracorporeal membrane oxygenation therapy in neonates with septic shock. J Pediatr Surg. May 1990;25(5):479-82. [Medline].

  32. DiCarlo JV, Dudley TE, Sherbotie JR, Kaplan BS, Costarino AT. Continuous arteriovenous hemofiltration/dialysis improves pulmonary gas exchange in children with multiple organ system failure. Crit Care Med. Aug 1990;18(8):822-6. [Medline].

  33. Ramamoorthy C, Anderson GD, Williams GD, Lynn AM. Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesth Analg. Feb 1998;86(2):283-9. [Medline].

Previous
Next
 
Chest radiograph of patient with cardiomegaly, which may accompany cardiogenic shock.
Determinants of cardiac function and oxygen delivery to tissues. Adapted from Strange GR. APLS: The Pediatric Emergency Medicine Course. 3rd ed. Elk Grove Village, Ill: American Academy of Pediatrics; 1998:34.
Hemodynamic response to hemorrhage model for cardiovascular response to hypovolemia from hemorrhage (based on normal data). Adapted from Schwaitzberg SD, Bergman KS, Harris BH. A pediatric trauma model of continuous hemorrhage. J Pediatr Surg. Jul 1988;23(7):605-9.
Definitions of shock include the following: Cold or warm shock: Decreased perfusion including decreased mental status, capillary refill more than 2 seconds (cold shock) or flash capillary refill (warm shock) and diminished (cold shock) or bounding (warm shock) peripheral pulses; mottled, cool extremities (cold shock) or decreased urine output less than 1mL/kg/h. Fluid-refractory, dopamine-resistant shock: Shock persists despite more than 60mL/kg fluid resuscitation in the first hour and dopamine infusion to 10mg/kg/min. Catecholamine-resistant shock: Shock persists despite use of catecholamines epinephrine or norepinephrine. Refractory shock: Shock persists despite goal-directed use of inotropic agents, vasopressors, vasodilators, and maintenance of metabolic (glucose and calcium) and hormonal (thyroid and hydrocortisone) homeostasis.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.